Method of Inhibiting Clostridium Difficile By Administration of Oritavancin
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described.
Attached files:Patents:WO 2,009,036,121
Inventor(s):
WILCOX MARK HARVEY [GB]; BAINES SIMON [GB]; LEHOUX DARIO [CA]; PARR THOMAS R [US]
Type of Offer:
Sale
« More Medical Patents« More Veterinary Science Patents